Rolke James (CIK 1693858) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-01). Recent activity: Sell REVB (10,115 shares), Sell REVB (8,521 shares), Buy REVB (532,829 shares), Buy REVB (390,614 shares), Buy REVB (30,095 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Executive Officer | Sell | 10,115 | $11,430 |
| 2026-02-05 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Executive Officer | Sell | 8,521 | $15,849 |
| 2026-01-12 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Executive Officer | Buy | 532,829 | $479,546 |
| 2025-10-31 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Executive Officer | Buy | 390,614 | $499,986 |
| 2025-02-13 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Executive Officer | Buy | 30,095 | $116,468 |
Source: SEC Form 4 filings · as of 2026-05-01